{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:58:56Z","timestamp":1794650336312,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T00:00:00Z","timestamp":1644105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T00:00:00Z","timestamp":1644105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21H160052"],"award-info":[{"award-number":["LY21H160052"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Medicine and Health Research Foundation","award":["2019KY020"],"award-info":[{"award-number":["2019KY020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>SWItch Sucrose Non-Fermentable (SWI\/SNF) chromatin-remodeling complex functions collectively as a tumor suppressor and the inactivation of any of its constituent components is frequently associated with tumor initiation and\/or progression. Most SWI\/SNF deficient tumors share common rhabdoid morphology. ARID1A is the most frequently dysregulated SWI\/SNF subunit in human cancer and inactivation of ARID1A is frequent across carcinomatous types while very rarely drives the tumorigenesis of sarcomas. Herein, we report a rare case of primary prostatic undifferentiated spindle cell sarcoma with focal rhabdoid morphology, harboring biallelic inactivation of <jats:italic>ARID1A<\/jats:italic> detected by next-generation sequencing with complete loss of ARID1A expression by immunohistochemistry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient is a 58-year-old man who presented with dysuria and obstructive voiding symptoms for 3\u2009month and was found to have a large, ill-defined, prostatic mass lesion with circumferential extension into the rectal wall on imaging studies. A needle biopsy showed a spindle cell undifferentiated sarcoma of the prostate and the patient was treated by chemotherapy of combined etoposide and cisplatin for 2\u2009months. A subsequent imaging study showed that the tumor was significantly enlarged, and the patient underwent laparoscopically radical prostatectomy. Gross examination showed a disrupted, 10\u2009\u00d7\u20097\u2009\u00d7\u20095\u2009cm, solid and cystic mass involving almost the entire prostate and sparing the seminal vesicle glands. Histologic examination showed that tumor was composed mainly of mildly atypical, oval to spindle-shaped cells, arranged in sheets and fascicles or herringbone-like patterns within a small amount of edematous to myxoid, vascularized stroma. Notably, groups of discohesive rhabdoid tumor cells with eccentric nuclei, prominent nucleoli, and abundant globular cytoplasm were observed. There were prominent mitotic figures, multifocal geographic necroses, and foci of lymphovascular invasion. Immunohistochemistry showed that the tumor cells were diffusely positive for TLE-1 and vimentin and focally positive for epithelial membrane antigen, AE1\/3, Cam5.2, SATB2, and CD34 (all in less than 10% tumor cells). Next-generation sequencing showed biallelic inactivation mutation of <jats:italic>ARID1A<\/jats:italic>; the predicted inactivating effect of ARID1A deletion was confirmed by immunohistochemical staining. After the surgery, the patient received an alternative combined chemotherapy of doxorubicin and ifosfamide for 5\u2009months. The patient died 9\u2009months after initial presentation due to extensive abdominal metastases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We report an ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate, adding to the growing spectrum of SWI\/SNF driven undifferentiated sarcoma. Rhabdoid cells can be a helpful morphological clue for promoting molecular and immunohistochemical analyses for deficiency of SWI\/SNF subunits, in the diagnostic workup of undifferentiated neoplasms featuring epithelioid or rhabdoid morphology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-022-01198-4","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T07:02:31Z","timestamp":1644130951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications"],"prefix":"10.1186","volume":"17","author":[{"given":"Wenjuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-7303","authenticated-orcid":false,"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,6]]},"reference":[{"issue":"6","key":"1198_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45(6):592\u2013601. https:\/\/doi.org\/10.1038\/ng.2628.","journal-title":"Nat Genet"},{"issue":"1","key":"1198_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","volume":"10","author":"J Masliah-Planchon","year":"2015","unstructured":"Masliah-Planchon J, Bi\u00e8che I, Guinebreti\u00e8re JM, Bourdeaut F, Delattre O. SWI\/SNF chromatin remodeling and human malignancies. Annu Rev Pathol. 2015;10(1):145\u201371. https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040445.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"1198_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1078-0432.CCR-13-0280","volume":"20","author":"X Wang","year":"2014","unstructured":"Wang X, Haswell JR, Roberts CW. Molecular pathways: SWI\/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights. Clin Cancer Res. 2014;20(1):21\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0280.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1198_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/path.5042","volume":"244","author":"MJ McBride","year":"2018","unstructured":"McBride MJ, Kadoch C. Disruption of mammalian SWI\/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities. J Pathol. 2018;244(5):638\u201349. https:\/\/doi.org\/10.1002\/path.5042.","journal-title":"J Pathol"},{"issue":"1","key":"1198_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.path.2018.10.006","volume":"12","author":"A Agaimy","year":"2019","unstructured":"Agaimy A. SWI\/SNF complex-deficient soft tissue neoplasms: a pattern-based approach to diagnosis and differential diagnosis. Surg Pathol Clin. 2019;12(1):149\u201363. https:\/\/doi.org\/10.1016\/j.path.2018.10.006.","journal-title":"Surg Pathol Clin"},{"issue":"3","key":"1198_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.semdp.2020.05.005","volume":"38","author":"IM Schaefer","year":"2021","unstructured":"Schaefer IM, Hornick JL. SWI\/SNF complex-deficient soft tissue neoplasms: an update. Semin Diagn Pathol. 2021;38(3):222\u201331. https:\/\/doi.org\/10.1053\/j.semdp.2020.05.005.","journal-title":"Semin Diagn Pathol"},{"key":"1198_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pharmthera.2018.05.001","volume":"190","author":"R Mathur","year":"2018","unstructured":"Mathur R. ARID1A loss in cancer: towards a mechanistic understanding. Pharmacol Ther. 2018;190:15\u201323. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.05.001.","journal-title":"Pharmacol Ther"},{"issue":"10","key":"1198_CR8","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/jamaoncol.2018.0723","volume":"4","author":"C Lucchesi","year":"2018","unstructured":"Lucchesi C, Khalifa E, Laizet Y, et al. Targetable alterations in adult patients with soft-tissue sarcomas: insights for personalized therapy. JAMA Oncol. 2018;4(10):1398\u2013404. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0723.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1198_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4161\/cbt.28411","volume":"15","author":"RC Wu","year":"2014","unstructured":"Wu RC, Wang TL, Shih IM. The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther. 2014;15(6):655\u201364. https:\/\/doi.org\/10.4161\/cbt.28411.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"1198_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cancergen.2015.03.005","volume":"208","author":"MS Abedalthagafi","year":"2015","unstructured":"Abedalthagafi MS, Bi WL, Merrill PH, Gibson WJ, Rose MF, du Z, et al. ARID1A and TERT promoter mutations in dedifferentiated meningioma. Cancer Genet. 2015;208(6):345\u201350. https:\/\/doi.org\/10.1016\/j.cancergen.2015.03.005.","journal-title":"Cancer Genet"},{"issue":"10","key":"1198_CR11","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","volume":"35","author":"TJ Hollmann","year":"2011","unstructured":"Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol. 2011;35(10):e47\u201363. https:\/\/doi.org\/10.1097\/PAS.0b013e31822b325b.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1198_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/pros.23375","volume":"77","author":"B De Bari","year":"2017","unstructured":"De Bari B, Stish B, Ball MW, et al. Adult prostatic sarcoma: a contemporary multicenter rare Cancer network study. Prostate. 2017;77(10):1160\u20136. https:\/\/doi.org\/10.1002\/pros.23375.","journal-title":"Prostate"},{"issue":"1","key":"1198_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.urology.2013.01.034","volume":"82","author":"X Wang","year":"2013","unstructured":"Wang X, Liu L, Tang H, Rao Z, Zhan W, Li X, et al. Twenty-five cases of adult prostate sarcoma treated at a high-volume institution from 1989 to 2009. Urology. 2013;82(1):160\u20135. https:\/\/doi.org\/10.1016\/j.urology.2013.01.034.","journal-title":"Urology"},{"issue":"3","key":"1198_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.urology.2014.05.036","volume":"84","author":"JE Musser","year":"2014","unstructured":"Musser JE, Assel M, Mashni JW, Sjoberg DD, Russo P. Adult prostate sarcoma: the memorial Sloan Kettering experience. Urology. 2014;84(3):624\u20138. https:\/\/doi.org\/10.1016\/j.urology.2014.05.036.","journal-title":"Urology"},{"issue":"6","key":"1198_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/00000478-200606000-00004","volume":"30","author":"M Herawi","year":"2006","unstructured":"Herawi M, Epstein JI. Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases. Am J Surg Pathol. 2006;30(6):694\u2013704. https:\/\/doi.org\/10.1097\/00000478-200606000-00004.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"1198_CR16","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/s41379-021-00818-6","volume":"34","author":"AM Acosta","year":"2021","unstructured":"Acosta AM, Sholl LM, Dickson BC, McKenney JK, Gordetsky JB, Pins MR, et al. Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes. Mod Pathol. 2021;34(9):1763\u201379. https:\/\/doi.org\/10.1038\/s41379-021-00818-6.","journal-title":"Mod Pathol"},{"issue":"1","key":"1198_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1066896919867763","volume":"28","author":"AD Olivas","year":"2020","unstructured":"Olivas AD, Antic T. Rhabdomyosarcoma of the adult prostate: a case report with complete molecular profile. Int J Surg Pathol. 2020;28(1):92\u20138. https:\/\/doi.org\/10.1177\/1066896919867763.","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"1198_CR18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/00000478-200405000-00011","volume":"28","author":"SY Jun","year":"2004","unstructured":"Jun SY, Choi J, Kang GH, Park SH, Ayala AG, Ro JY. Synovial sarcoma of the kidney with rhabdoid features: report of three cases. Am J Surg Pathol. 2004;28(5):634\u20137. https:\/\/doi.org\/10.1097\/00000478-200405000-00011.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1198_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00428-021-03189-0","volume":"479","author":"Y Ito","year":"2021","unstructured":"Ito Y, Kohashi K, Endo M, Yoshimoto M, Ishihara S, Toda Y, et al. Clinicopathological and prognostic significance of H3K27 methylation status in malignant peripheral nerve sheath tumor: correlation with skeletal muscle differentiation. Virchows Arch. 2021;479(6):1233\u201344. https:\/\/doi.org\/10.1007\/s00428-021-03189-0. Epub ahead of print.","journal-title":"Virchows Arch"},{"issue":"10","key":"1198_CR20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/01.pas.0000209838.92842.bf","volume":"30","author":"DE Hansel","year":"2006","unstructured":"Hansel DE, Epstein JI. Sarcomatoid carcinoma of the prostate: a study of 42 cases. Am J Surg Pathol. 2006;30(10):1316\u201321. https:\/\/doi.org\/10.1097\/01.pas.0000209838.92842.bf.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1198_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/modpathol.2016.230","volume":"30","author":"IM Schaefer","year":"2017","unstructured":"Schaefer IM, Agaimy A, Fletcher CD, et al. Claudin-4 expression distinguishes SWI\/SNF complex-deficient undifferentiated carcinomas from sarcomas. Mod Pathol. 2017;30(4):539\u201348. https:\/\/doi.org\/10.1038\/modpathol.2016.230.","journal-title":"Mod Pathol"},{"issue":"2","key":"1198_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","volume":"15","author":"N Rekhtman","year":"2020","unstructured":"Rekhtman N, Montecalvo J, Chang JC, Alex D, Ptashkin RN, Ai N, et al. SMARCA4-deficient thoracic Sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas. J Thorac Oncol. 2020;15(2):231\u201347. https:\/\/doi.org\/10.1016\/j.jtho.2019.10.023.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"1198_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000438","volume":"8","author":"R Okamura","year":"2020","unstructured":"Okamura R, Kato S, Lee S, Jimenez RE, Sicklick JK, Kurzrock R. ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1\/PD-L1 immunotherapy. J Immunother Cancer. 2020;8(1):e000438. https:\/\/doi.org\/10.1136\/jitc-2019-000438.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"1198_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nm.3799","volume":"21","author":"BG Bitler","year":"2015","unstructured":"Bitler BG, Aird KM, Garipov A, Li H, Amatangelo M, Kossenkov AV, et al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat Med. 2015;21(3):231\u20138. https:\/\/doi.org\/10.1038\/nm.3799.","journal-title":"Nat Med"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01198-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T07:03:00Z","timestamp":1644130980000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01198-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1198"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01198-4","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,6]]},"assertion":[{"value":"28 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Samples were used in accordance with ethical guidelines for the use of retrospective tissue samples provided by the local ethics committee of the Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}